Periodic monitoring Active

Key facts

  • In June 2024, 27 countries reported measles data to The European Surveillance System (TESSy), with 1 891 cases reported by 16 countries. Eleven countries reported zero cases.
  • Through its epidemic intelligence activities, ECDC has identified 2 950 new measles cases in 17 EU/EEA countries that were not reported before the last monthly update.
  • In 2024, 19 measles-related deaths have been reported in Romania (18) and Ireland (1).
  • Overall in the EU/EEA over the last 12 months there has been high measles activity, however the situation varies by country: some countries have reported large and/or ongoing outbreaks and others have sustained no or very low transmission.
  • Relevant updates outside the EU/EEA are available for Switzerland, the UK, and countries in the Western Balkan and WHO Regions.

Overview

In June 2024, 27 countries reported measles data to The European Surveillance System (TESSy), with 1 891 cases reported by 16 countries. Eleven countries reported zero cases.

In the most recent 12-month period, from 1 July 2023 to 30 June 2024, 30 EU/EEA Member States reported 17 273 measles cases, 13 308 (77.0%) of which were laboratory-confirmed. During this 12-month period, three countries (Latvia, Luxembourg and Liechtenstein) reported zero cases. The highest number of cases were reported by Romania (13 879), Italy (753), Austria (514), Belgium (493) and France (436). The highest notification rates were observed in infants under one year of age (559.3 cases per million) and children aged 1-4 years (333.8 cases per million). Thirteen deaths attributable to measles were reported to ECDC during the 12-month period by Romania (twelve) and Ireland (one). Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases and the Measles and Rubella monthly report.

Complementary epidemic intelligence surveillance with data collection conducted between 6 and 12 August 2024 from official public and media sources detected 2 950 new suspected and/or confirmed measles cases that were not reported before the last monthly update. New cases were reported in 17 EU/EEA countries in recent months: Austria (new: 26, total: 490), Belgium (new: 10, total: 275), Bulgaria (new: 7, total: 24), Croatia (new: 10, total: 18), Czechia (new: 1, total: 30), Denmark (new: 1, total: 20), France (new: 135, total: 300), Germany (new: 9, total: 399), Ireland (new: 13, total: 82, including 1 death), Italy (new: 251, total: 807), Netherlands (new: 42, total: 147), Norway (new: 3, total: 9), Poland (new: 24, total: 246), Portugal (new: 4, total: 34), Romania (new: 2 392 cases, total: 19 785, including 18 deaths), Spain (new: 20, total: 181), Sweden (new: 2, total: 23).

Overall, 19 measles-related deaths have been reported in the EU/EEA in 2024, in Romania (18) and in Ireland (1).

Relevant updates for outside the EU/EEA are available for Switzerland, the UK, and countries in the Western Balkan and WHO Regions.

Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to TESSy. Data presented in the two monthly reports may differ.

Epidemiological summary for EU/EEA countries with epidemic intelligence updates since last month:

Austria reported 490 confirmed measles cases in 2024 as of 09 August 2024, an increase of 26 cases since 09 July 2024. Of the 479 cases for which hospitalisation information was available, 102 individuals (21%) were hospitalised, including four in the intensive care unit. All regions reported at least one case of measles in 2024, with most of the cases reported in Lower Austria (116, 24%) and Tyrol (88, 18%).

 

Belgium reported 275 confirmed measles cases in TESSy between January to June 2024 and as of 12 August 2024, an increase of 10 cases since 10 July 2024.

Bulgaria reported 24 cases in 2024 and as of 12 August 2024, an increase of seven cases since the 8 July 2024. No cases were reported for the same period of the previous year.

Croatia  reported 18 cases of measles in 2024 and as of 6 June 2024, an increase of ten since 13 May 2024.

Czechia reported 30 cases in January to July 2024, an increase of one case since June.

Denmark reported 20 cases in 2024 and as of 8 August 2024, an increase by one case since the monthly update in July.

France reported 300 measles cases in TESSy between January and June 2024, an increase of 135 cases since monthly report in June. Of these, 35 cases were reported in June.

Germany reported 399 confirmed and suspected measles cases in 2024 (data as of 8 August 2024), an increase of nine cases since 10 July 2024.

Ireland has reported 82 confirmed measles cases as of 9 August 2024, an increase of 13 cases since the last monthly update on 9 July 2024. In addition, 11 cases are currently under investigation. Outbreaks have been reported across all six Health Service Executive (HSE) regions.

Italy reported 807 measles cases between 1 January and 31 July 2024 and as of 8 August 2024. This is an increase of 251 since 11 June 2024 report. Cases have been reported from 17/21 regions, mostly in unvaccinated individuals (90%). At a national level, the incidence in this period was 23.5 cases per million inhabitants.

 

Netherlands reported 147 cases of measles in 2024 and as of 24 July 2024, an increase of 42 cases since 26 June 2024.

Norway reported nine cases as of 12 August 2024, an increase of three since 9 July 2024.

 

Poland reported 246 cases of measles from January to 31 July 2024 and as of 8 August 2024, an increase of 24 cases since 30 June 2024.

Portugal has reported 34 confirmed measles cases from January to 23 July 2024, an increase of four cases since 2 June 2024. Of these, 21 (62%) cases were unvaccinated.

Romania has reported 19 785 cases, including 18 deaths, from January to 4 August 2024, an increase of 2 052 cases since 7 July 2024. This nationwide outbreak started in 2023, and 22 590 confirmed measles cases, including 21 deaths, have been reported from 1 January 2023 to 4 August 2024. The cases have been reported in all 41 counties and the Municipality of Bucharest. Among cases with known vaccination status (20 117), unvaccinated individuals across all age groups accounted for 90%.

 

Spain reported 181 measles cases from 1 January to 28 July 2024, an increase of 20 cases since 7 July 2024. Of these, 30 cases were imported.

Sweden has reported 23 cases in 2024 as of 8 August, an increase of two cases since 9 June 2024. Of these, 15 (65%) were imported.

Relevant epidemiological summary for countries outside the EU/EEA:

Switzerland has reported 93 cases in 2024 and as of 5 August 2024, an increase of three cases since 9 July 2024.

United Kingdom has reported several outbreaks of measles in 2024. As of 22 July, 2 149 measles cases have been confirmed in England in 2024. In Northern Ireland 14 cases were confirmed in 2024 and as of 1 August 2024. In Scotland, there have been 16 laboratory-confirmed measles cases in 2024 and as of 7 August 2024.

Western Balkan: Several countries continue to report reported increased measles cases this year.

Bosnia and Herzegovina

The Republic of Srpska has reported 296 measles cases as of 2 August 2024, an increase of 45 cases since 5 July 2024. Most cases were in the age group 1-4 years (156 cases, 53%). The city of Bijeljina contributed 75% of the confirmed cases. As of 12 August 2024, the Federation of Bosnia and Herzegovina notified 7060 measles cases, including one death in an 18-year old unvaccinated male, in 2024, an increase of 828 cases and one death since 7 July 2024. Most notified cases are in the age group 1-4 years (2 858, 40%). Of all notified cases, 6 053 (86%) were unvaccinated. As of 8 August 2024, Brcko district reported 188 measles cases in 2024. This is an increase of 74 cases since May.

 

Serbia reported 255 measles cases as of 7 August 2024, an increase by 74 cases since 7 July.

Montenegro reported 12 measles cases as of 2 August 2024, an increase by five measles cases since 5 July, of which 10 (83%) were in unvaccinated individuals.

Summary for WHO regional offices

WHO Regional Office for Europe (WHO/EUROPE) reported 84 932 measles cases in 2024 as of 5 August 2024. The five non-EU/EEA countries reporting the most measles cases: Kazakhstan (27 330), Azerbaijan (16 633), Russia (13 018), Kyrgyzstan (11 759), and United Kingdom (2 123).

The numbers provided to WHO for EU/EEA countries are from TESSy data, updated monthly and available on ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting time the numbers may not correspond to the data from epidemic intelligence screening.

WHO Regional Office for Africa (WHO AFRO) has reported 58 551 measles cases in 2024 as of 5 August 2024. The highest number of cases was reported from Ethiopia (25 109), Nigeria (7 073), Burkina Faso (6 312), Cote d’Ivoire (5 624) and Democratic Republic of the Congo (2 402).

WHO Regional Office for the Americas (WHO PAHO) has reported 301 confirmed measles cases in 2024 as of 2 August 2024. Over 50% of cases were imported and 70% in unvaccinated individuals. Most cases (203) were confirmed in the USA.

WHO Regional Office for the Eastern Mediterranean (WHO EMRO) has reported 63 252 measles cases in 2024 as of 5 August 2024. The highest number of cases was reported from Iraq (29 769), Pakistan (17 985), Yemen (7 307), Afghanistan (5 532) and Somalia (907).

WHO Regional Office for South-East Asia (WHO SEARO) has reported 22 522 measles cases in 2024 as of 5 August 2024. The highest number of cases was reported from India (16 851), Indonesia (3 325), Thailand (1 746), Sri Lanka (221), and Nepal (176).

 

WHO Regional Office for the Western Pacific (WHO WPRO) has reported 8 033 measles cases in 2024 as of 5 August 2024. Nine countries reported cases: Malaysia (3 364), the Philippines (3 039), Viet Nam (829) China (536), and Cambodia (83).

ECDC assessment

The overall number of measles cases in the EU/EEA has been steadily increasing since June 2023. Measles cases may continue increasing in the EU/EEA in the coming months due to reported sub-optimal vaccination coverage for measles- containing vaccines (MCV) in a number of EU/EEA countries (<95% in a many of these countries), and the high probability of importation from areas experiencing high circulation. In addition, the recent report of a majority of cases having acquired the disease within the reported country through community/local transmission, indicates a higher probability of being exposed to the virus within the EU/EEA than in previous months.

As the number of cases is expected to rise in the near future, ECDC urges EU/EEA public health authorities to focus on the following areas:

  • Close immunity gaps, achieve and maintain high vaccination coverage for MCV (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
  • Strive towards high-quality surveillance, and adequate public health capacity, especially for early detection, diagnosis, response, and control of outbreaks.
  • Increase the clinical awareness of health professionals.
  • Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of sub-optimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
  • Address barriers and engage with underserved populations. Systemic barriers that impact vaccine uptake in under-served, isolated and difficult-to-reach populations need to be monitored and addressed with targeted strategies, to reduce inequalities in vaccine uptake.


ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response' published in February 2024 and the conclusions of that remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.  

Actions

ECDC is monitoring the measles situation through its epidemic intelligence activities, which supplement monthly outputs with measles surveillance data from TESSy, routinely submitted by 30 EU/EEA countries. ECDC's latest advice on measles is available in the Threat Assessment Brief, 'Measles on the rise in the EU/EEA: Considerations for a public health response', published on 15 February 2024.

Latest updates for this event

View all